Amyotrophic Lateral Sclerosis and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Amyotrophic Lateral Sclerosis (ALS) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Amyotrophic Lateral Sclerosis (ALS) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Amyotrophic Lateral Sclerosis (ALS) Overall Market Size
2.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size: 2021 VS 2028
2.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Amyotrophic Lateral Sclerosis (ALS) Sales: 2017-2028
3 Company Landscape
3.1 Top Amyotrophic Lateral Sclerosis (ALS) Players in Global Market
3.2 Top Global Amyotrophic Lateral Sclerosis (ALS) Companies Ranked by Revenue
3.3 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Companies
3.4 Global Amyotrophic Lateral Sclerosis (ALS) Sales by Companies
3.5 Global Amyotrophic Lateral Sclerosis (ALS) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Amyotrophic Lateral Sclerosis (ALS) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Amyotrophic Lateral Sclerosis (ALS) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis (ALS) Players in Global Market
3.8.1 List of Global Tier 1 Amyotrophic Lateral Sclerosis (ALS) Companies
3.8.2 List of Global Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis (ALS) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Market Size Markets, 2021 & 2028
4.1.2 Riluzole
4.1.3 Edaravone (Radicava)
4.1.4 Other
4.2 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Revenue & Forecasts
4.2.1 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2022
4.2.2 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Revenue, 2023-2028
4.2.3 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share, 2017-2028
4.3 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Sales & Forecasts
4.3.1 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2022
4.3.2 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Sales, 2023-2028
4.3.3 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share, 2017-2028
4.4 By Type - Global Amyotrophic Lateral Sclerosis (ALS) Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Drugs Store
5.1.4 Other
5.2 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Revenue & Forecasts
5.2.1 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2022
5.2.2 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Revenue, 2023-2028
5.2.3 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share, 2017-2028
5.3 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Sales & Forecasts
5.3.1 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2022
5.3.2 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Sales, 2023-2028
5.3.3 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share, 2017-2028
5.4 By Application - Global Amyotrophic Lateral Sclerosis (ALS) Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Market Size, 2021 & 2028
6.2 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Revenue & Forecasts
6.2.1 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2022
6.2.2 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Revenue, 2023-2028
6.2.3 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share, 2017-2028
6.3 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Sales & Forecasts
6.3.1 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2022
6.3.2 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Sales, 2023-2028
6.3.3 By Region - Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2028
6.4.2 By Country - North America Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2028
6.4.3 US Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.4.4 Canada Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.4.5 Mexico Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2028
6.5.2 By Country - Europe Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2028
6.5.3 Germany Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.5.4 France Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.5.5 U.K. Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.5.6 Italy Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.5.7 Russia Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.5.8 Nordic Countries Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.5.9 Benelux Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2028
6.6.2 By Region - Asia Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2028
6.6.3 China Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.6.4 Japan Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.6.5 South Korea Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.6.6 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.6.7 India Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2028
6.7.2 By Country - South America Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2028
6.7.3 Brazil Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.7.4 Argentina Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales, 2017-2028
6.8.3 Turkey Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.8.4 Israel Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.8.5 Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
6.8.6 UAE Amyotrophic Lateral Sclerosis (ALS) Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Mitsubishi Tanabe Pharma
7.1.1 Mitsubishi Tanabe Pharma Corporate Summary
7.1.2 Mitsubishi Tanabe Pharma Business Overview
7.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.1.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.1.5 Mitsubishi Tanabe Pharma Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.2.4 Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.2.5 Sanofi Key News
7.3 Mylan Pharma
7.3.1 Mylan Pharma Corporate Summary
7.3.2 Mylan Pharma Business Overview
7.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.3.4 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.3.5 Mylan Pharma Key News
7.4 Apotex
7.4.1 Apotex Corporate Summary
7.4.2 Apotex Business Overview
7.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.4.4 Apotex Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.4.5 Apotex Key News
7.5 Glemark Generics
7.5.1 Glemark Generics Corporate Summary
7.5.2 Glemark Generics Business Overview
7.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.5.4 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.5.5 Glemark Generics Key News
7.6 Covis Pharma
7.6.1 Covis Pharma Corporate Summary
7.6.2 Covis Pharma Business Overview
7.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.6.4 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.6.5 Covis Pharma Key News
7.7 Sun Pharma
7.7.1 Sun Pharma Corporate Summary
7.7.2 Sun Pharma Business Overview
7.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.7.4 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.7.5 Sun Pharma Key News
7.8 Lunan Pharma
7.8.1 Lunan Pharma Corporate Summary
7.8.2 Lunan Pharma Business Overview
7.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Major Product Offerings
7.8.4 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales and Revenue in Global (2017-2022)
7.8.5 Lunan Pharma Key News
8 Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity, Analysis
8.1 Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity, 2017-2028
8.2 Amyotrophic Lateral Sclerosis (ALS) Production Capacity of Key Manufacturers in Global Market
8.3 Global Amyotrophic Lateral Sclerosis (ALS) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Amyotrophic Lateral Sclerosis (ALS) Supply Chain Analysis
10.1 Amyotrophic Lateral Sclerosis (ALS) Industry Value Chain
10.2 Amyotrophic Lateral Sclerosis (ALS) Upstream Market
10.3 Amyotrophic Lateral Sclerosis (ALS) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Amyotrophic Lateral Sclerosis (ALS) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Amyotrophic Lateral Sclerosis (ALS) in Global Market
Table 2. Top Amyotrophic Lateral Sclerosis (ALS) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Companies, 2017-2022
Table 5. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Companies, (K MT), 2017-2022
Table 6. Global Amyotrophic Lateral Sclerosis (ALS) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Amyotrophic Lateral Sclerosis (ALS) Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Amyotrophic Lateral Sclerosis (ALS) Product Type
Table 9. List of Global Tier 1 Amyotrophic Lateral Sclerosis (ALS) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis (ALS) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Amyotrophic Lateral Sclerosis (ALS) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Amyotrophic Lateral Sclerosis (ALS) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), 2017-2022
Table 15. By Type - Global Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), 2023-2028
Table 16. By Application ? Global Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Amyotrophic Lateral Sclerosis (ALS) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Amyotrophic Lateral Sclerosis (ALS) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), 2017-2022
Table 20. By Application - Global Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), 2023-2028
Table 21. By Region ? Global Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Amyotrophic Lateral Sclerosis (ALS) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Amyotrophic Lateral Sclerosis (ALS) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), 2017-2022
Table 25. By Region - Global Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), 2023-2028
Table 26. By Country - North America Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Amyotrophic Lateral Sclerosis (ALS) Sales, (K MT), 2017-2022
Table 29. By Country - North America Amyotrophic Lateral Sclerosis (ALS) Sales, (K MT), 2023-2028
Table 30. By Country - Europe Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Amyotrophic Lateral Sclerosis (ALS) Sales, (K MT), 2017-2022
Table 33. By Country - Europe Amyotrophic Lateral Sclerosis (ALS) Sales, (K MT), 2023-2028
Table 34. By Region - Asia Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Amyotrophic Lateral Sclerosis (ALS) Sales, (K MT), 2017-2022
Table 37. By Region - Asia Amyotrophic Lateral Sclerosis (ALS) Sales, (K MT), 2023-2028
Table 38. By Country - South America Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Amyotrophic Lateral Sclerosis (ALS) Sales, (K MT), 2017-2022
Table 41. By Country - South America Amyotrophic Lateral Sclerosis (ALS) Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales, (K MT), 2023-2028
Table 46. Mitsubishi Tanabe Pharma Corporate Summary
Table 47. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product Offerings
Table 48. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi Amyotrophic Lateral Sclerosis (ALS) Product Offerings
Table 51. Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Mylan Pharma Corporate Summary
Table 53. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product Offerings
Table 54. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Apotex Corporate Summary
Table 56. Apotex Amyotrophic Lateral Sclerosis (ALS) Product Offerings
Table 57. Apotex Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Glemark Generics Corporate Summary
Table 59. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product Offerings
Table 60. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Covis Pharma Corporate Summary
Table 62. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product Offerings
Table 63. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Sun Pharma Corporate Summary
Table 65. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product Offerings
Table 66. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Lunan Pharma Corporate Summary
Table 68. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product Offerings
Table 69. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Amyotrophic Lateral Sclerosis (ALS) Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 71. Global Amyotrophic Lateral Sclerosis (ALS) Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Amyotrophic Lateral Sclerosis (ALS) Production by Region, 2017-2022 (K MT)
Table 73. Global Amyotrophic Lateral Sclerosis (ALS) Production by Region, 2023-2028 (K MT)
Table 74. Amyotrophic Lateral Sclerosis (ALS) Market Opportunities & Trends in Global Market
Table 75. Amyotrophic Lateral Sclerosis (ALS) Market Drivers in Global Market
Table 76. Amyotrophic Lateral Sclerosis (ALS) Market Restraints in Global Market
Table 77. Amyotrophic Lateral Sclerosis (ALS) Raw Materials
Table 78. Amyotrophic Lateral Sclerosis (ALS) Raw Materials Suppliers in Global Market
Table 79. Typical Amyotrophic Lateral Sclerosis (ALS) Downstream
Table 80. Amyotrophic Lateral Sclerosis (ALS) Downstream Clients in Global Market
Table 81. Amyotrophic Lateral Sclerosis (ALS) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Amyotrophic Lateral Sclerosis (ALS) Segment by Type
Figure 2. Amyotrophic Lateral Sclerosis (ALS) Segment by Application
Figure 3. Global Amyotrophic Lateral Sclerosis (ALS) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Amyotrophic Lateral Sclerosis (ALS) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Amyotrophic Lateral Sclerosis (ALS) Revenue, 2017-2028 (US$, Mn)
Figure 7. Amyotrophic Lateral Sclerosis (ALS) Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Amyotrophic Lateral Sclerosis (ALS) Revenue in 2021
Figure 9. By Type - Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share, 2017-2028
Figure 10. By Type - Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Amyotrophic Lateral Sclerosis (ALS) Price (USD/MT), 2017-2028
Figure 12. By Application - Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share, 2017-2028
Figure 13. By Application - Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Amyotrophic Lateral Sclerosis (ALS) Price (USD/MT), 2017-2028
Figure 15. By Region - Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share, 2017-2028
Figure 16. By Region - Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share, 2017-2028
Figure 19. US Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share, 2017-2028
Figure 24. Germany Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 25. France Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Amyotrophic Lateral Sclerosis (ALS) Sales Market Share, 2017-2028
Figure 33. China Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 37. India Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share, 2017-2028
Figure 40. Brazil Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share, 2017-2028
Figure 44. Turkey Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Amyotrophic Lateral Sclerosis (ALS) by Region, 2021 VS 2028
Figure 50. Amyotrophic Lateral Sclerosis (ALS) Industry Value Chain
Figure 51. Marketing Channels
Industry Market Size
